郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity.

期刊：PloS one发表年份：2014作者：John A Corbin; Vinay Bhaskar; Ira D Goldfine; Daniel H Bedinger; Angela Lau; Kristen Michelson; Lisa M Gross; Betty A Maddux; Hua F Kuan; Catarina Tran; Llewelyn Lao; Masahisa Handa; Susan R Watson; Ajay J Narasimha; Shirley Zhu; Raphael Levy; Lynn W
阅读更多 →

代谢疾病A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits.

期刊：BMC pharmacology & toxicology发表年份：2014作者：Tharappel M Anil; Anilkumar Dandu; KrishnaReddy Harsha; Jaideep Singh; Nitya Shree; Venkatesh Satish Kumar; Mudigere N Lakshmi; Venkategowda Sunil; Chandrashekaran Harish; Gundalmandikal V Balamurali; Baisani S Naveen Kumar; Aralakuppe S Gopala; Shiv
阅读更多 →

代谢疾病Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes.

期刊：Metabolism: clinical and experimental发表年份：2014作者：Hussein N Yassine; Alexandra Belopolskaya; Christina Schall; Craig S Stump; Serrine S Lau; Peter D Reaven
阅读更多 →

代谢疾病Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.

期刊：PloS one发表年份：2014作者：Tadeusz Kolodka; Matthew L Charles; Arvind Raghavan; Ilian A Radichev; Christina Amatya; Jacob Ellefson; Alexei Y Savinov; Abhijeet Nag; Mark S Williams; Mark S Robbins
阅读更多 →